No Data
No Data
No Data
No Data
No Data
Jiashitang (002462.SZ) reported 2023 annual results, net profit of 250 million yuan, a year-on-year decrease of 15.79%
Jiashitang (002462.SZ) released its 2023 annual report. The company achieved 299 operating income during the reporting period...
Zhitong FinanceApr 28 07:28 ET
Jiashitang (002462.SZ): Zhao Baofu no longer holds the position of director
Jiashitang (002462.SZ) announced that the company recently received information from the shareholder China Everbright Group Co., Ltd. about the company...
Zhitong FinanceMar 13 06:03 ET
Benign Growth For Cachet Pharmaceutical Co., Ltd. (SZSE:002462) Underpins Stock's 30% Plummet
Cachet Pharmaceutical Co., Ltd. (SZSE:002462) shareholders that were waiting for something to happen have been dealt a blow with a 30% share price drop in the last month. Instead of being rewarded,
Simply Wall StFeb 5 17:33 ET
The Returns On Capital At Cachet Pharmaceutical (SZSE:002462) Don't Inspire Confidence
There are a few key trends to look for if we want to identify the next multi-bagger. Firstly, we'd want to identify a growing return on capital employed (ROCE) and then alongside that, an ever-increa
Simply Wall StJan 23 01:11 ET
[Instant Analysis of BT Financial Report] Jiashitang's 2023 Interim Report: Operating income has increased steadily, net cash flow has increased dramatically
The 2023 interim report of Jiashitang (stock code: 002462) has been published. This article will interpret its financial data from the perspective of a financial analyst. First, let's take a look at Jiashitang's revenue. Revenue for the reporting period was 14,877,717,780.55 yuan, an increase of 17.09% compared to 12,706,434,721.05 yuan for the same period last year. This is mainly due to the increase in revenue from the pharmaceutical wholesale business. However, the net profit attributable to shareholders of listed companies during the reporting period was 155,489,204.07 yuan, compared with 169 in the same period last year.
businesstimes cnSep 15, 2023 04:33 ET
Investors Can Find Comfort In Cachet Pharmaceutical's (SZSE:002462) Earnings Quality
Soft earnings didn't appear to concern Cachet Pharmaceutical Co., Ltd.'s (SZSE:002462) shareholders over the last week. We did some digging, and we believe the earnings are stronger than they seem.
Simply Wall StSep 6, 2023 18:05 ET
No Data
No Data